Inhye Ahn, MD @inhyeahn X Profile

Inhye Ahn, MD

@inhyeahn

Followers

289

Following

89

Media

5

Statuses

14

Hematologist-oncologist | CLL Researcher | Faculty @DanaFarber | Graduate of @NIH Fellowship

Boston, MA

Joined August 2015

Don't wanna be here? Send us removal request.

Inhye Ahn, MD

@inhyeahn

2 years

What did we learn from the past decade with ibrutinib in #CLL? #NIH phase 2 study data presented by Dr. Adrian Wiestner showed:.- Median PFS of 81 months for TN-CLL with TP53 alterations.- Median PFS was even longer for TN-CLL without TP53 alterations.- IGHV status matters.

0

1

16

Inhye Ahn, MD

@inhyeahn

2 years

Excellent session at #iwCLL2023 on prevention of infection by @carsten_niemann, Clare Sun, Yair @herishanu, Carolyn Owen, and Chris Pleyer. Going home with new and practical ideas on vaccination in #CLL.

0

10

Inhye Ahn, MD

@inhyeahn

2 years

Thanks #DAVABermudaHeme for the chance to be part of this amazing meeting.

Kathryn Gallaway, MD

@KE_Gallaway

2 years

@inhyeahn kicks off our BTKi session with an excellent overview of resistance mechanisms in CLL. As BTKi options continue to expand, deep understanding of the development of these mutations will help guide sequencing strategies and novel MOAs for future agents. #DAVABermudaHeme

0

9

Inhye Ahn, MD

@inhyeahn

2 years

A reunion with @DrSwami_Iyer in @icmlugano who was my attending during residency training—it was just a few years back :D

1

0

13

Inhye Ahn, MD

@inhyeahn

2 years

Welcoming @JiEunJang120 to Twitter!.

0

Inhye Ahn, MD

@inhyeahn

2 years

B and NK cell docs on a lunch date! Had a wonderful time with @romeerizwan and Ji Eun Jang, our visiting professor from @yonseiunivon, at a Korean restaurant.

2

1

18

Inhye Ahn, MD

@inhyeahn

2 years

RT @calliecoombsmd: Big change to NCCN guidelines which now include pirtobrutinib for double exposed CLL pts - hopefully this helps with in….

0

14

0

Inhye Ahn, MD

@inhyeahn

2 years

RT @Othman_Al_Sawaf: Check out our latest work on transcriptomic profiles of #CLL, drivers of MRD response and 5-year results from CLL14 –….

0

25

0

Inhye Ahn, MD

@inhyeahn

4 years

RT @ChristineRyanMD: Great end to an exciting #ASH21 conference with an amazing talk by @DrMDavids on therapies for p53 mutant hematologic….

0

2

0

Inhye Ahn, MD

@inhyeahn

4 years

RT @Othman_Al_Sawaf: Delighted to share our latest paper in #JCO, in which we suggest an MRD growth model of CLL, including new data from t….

0

11

0

Inhye Ahn, MD

@inhyeahn

4 years

RT @DrMDavids: Start of a new era here in the @DanaFarber CLL Center. First official clinic day for our newest CLL expert @inhyeahn. Welc….

0

6

0

Inhye Ahn, MD

@inhyeahn

8 years

Dr. Gulley @gulleyj1 talks about #Immunotherapy combination strategy at #AACR17. @NCICCR_MOS

1